[Lymph fistulae following lymph node dissections--prevention and treatment using fibrin gluing].
The fibrin sealing was employed in connection with lymph node dissections - on one hand intraoperatively in order to avoid lymph fistulae (n = 26), on the other hand postoperatively in treatment of manifest lymph fistulae (n = 9). Thereby lymph fistulae could be avoided in 96.2% (n = 25) resp. a quick successful treatment of the lymph fistulae could be achieved in 7 of 9 cases (77%). On the average a quantity of 1 ml of fibrin sealant was sufficient; a high concentration of aprotinin (3500 IU) and thrombin (500 IU) was chosen. No side effects on part of the fibrin sealing were noted.
D001365:Axilla / Q000601:surgery; D004322:Drainage; D004338:Drug Combinations / Q000627:therapeutic use; D005176:Factor XIII / Q000627:therapeutic use*; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000627:therapeutic use*; D005402:Fistula / Q000601:surgery*; D006801:Humans; D007264:Inguinal Canal / Q000601:surgery; D008197:Lymph Node Excision; D008206:Lymphatic Diseases / Q000601:surgery*; D011183:Postoperative Complications / Q000601:surgery*; D013917:Thrombin / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects
D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen; D005176:Factor XIII; D013917:Thrombin
Lymphfisteln nach Lymphknotendissektionen--Verhütung und Behandlung mit Hilfe der Fibrinklebung.